Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April (Michelle F Davis/Bloomberg)

Michelle F Davis / Bloomberg:
Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April  —  – New investor Franklin Templeton leads round with Altimeter  — Companies using firm’s software include Regeneron, Eli Lilly